Surrey Heartlands

Joint Formulary & PAD

Dydrogesterone - Menstrual symptoms

You are here : Home > Formulary Search > Dydrogesterone - Menstrual symptoms

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NFD2
SPC
Restrictions / Comments :
Important

This drug has not been assessed for inclusion on the formulary. Please contact your pharmacy team for advice.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dydrogesterone
Indication :
Menstrual symptoms
Group Name :
Keywords :
Dysmenorrhoea, Endometriosis, Premenstrual symptoms, Monorrhagia, dysfunctional uterine bleeding, secondary amenorrhoea
Brand Names Include :
Nalvee
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

03 Sep 25 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC).  As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. 

Before prescribing, it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission.

Other Indications

Below are listed other indications that Dydrogesterone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Menstrual symptoms.